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Several imaging technologies have become available
for diagnostic cardiac imaging, such as single photon
emission computed tomography (SPECT) [1–7], pos-
itron emission tomography (PET) [8], magnetic
resonance imaging (MRI) [9–13], and coronary com-
puted tomography angiography (CTA) [14–38]. These
techniques individually offer unique advantages, but
also suffer from specific limitations. CTA mainly
provides anatomical information, MRI offers anatom-
ical and functional information, whereas SPECT and
PET offer metabolic and functional information.
In particular gated SPECT provides functional infor-
mation as this modality can be applied during con-
ventional stress and allows the calculation of left
ventricular volumes and ejection fraction. Software
techniques have been developed to combine cardiac
images from different modalities and generate com-
posite multimodality images, allowing better diagnosis
than obtained from images analyzed separately.
Hybrid scanners (SPECT/CT and PET/CT) have also
been proposed for integrated cardiac imaging.
However, several studies have claimed that CTA as
a stand-alone imaging modality may provide useful
and practical information in patients with suspected
and known coronary artery disease (CAD) [37–41].
Gaemperli et al. [39] showed that CTA offers a
valuable alternative for the diagnosis of CAD but its
value in the detection of functionally relevant coronary
stenoses remains uncertain. The authors compared the
accuracy of 64-slice CTA with that of myocardial
perfusion imaging using perfusion SPECT as the gold
standard for the detection of functionally CAD in 100
consecutive patients. Using a cut-off value of [75%
area stenosis, CTA yielded a sensitivity of 75%, a
specificity of 95%, a negative predictive value of 93%,
a positive predictive value of 50% and an accuracy of
94%, respectively. It was concluded that CTA is a
reliable tool to rule out functionally relevant CAD in a
non-selected population with an intermediate pretest
likelihood of disease. However, an abnormal CTA
proved to be a poor predictor of myocardial ischemia.
Min et al. [40] assessed the costs and clinical
outcomes in individuals without known CAD who
underwent CTA compared with those in matched
patients who underwent myocardial perfusion SPECT.
One-year CAD costs (additional diagnostic coronary
testing, CAD hospitalization, and coronary procedural
and revascularization costs) and clinical outcomes
were examined in individuals without known CAD
who underwent CTA (n = 1,647) compared with
those who underwent myocardial perfusion SPECT
(n = 6,588). The CTA group was less likely to
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undergo coronary angiography than the myocardial
perfusion SPECT group. Adjusted CAD costs in the
CTA group were 25.9% lower than in the myocardial
perfusion SPECT group. Consequently, individuals
without known CAD who underwent CTA as an initial
diagnostic test compared with those who underwent
SPECT incurred lower health care costs with similar
rates of myocardial infarction and CAD-related
hospitalization.
In the present issue of the International Journal of
Cardiovascular Imaging, Haramati et al. [41] evaluated
the utility of CTA for demonstrating CAD in inner-city
outpatients. CTA was prospectively compared with
stress SPECT myocardial perfusion imaging in 61
patients in an ethnically diverse, gender-balanced
population. A luminal stenosis of[70% on CTA was
considered positive. Results were compared with
SPECT perfusion defects and correlated with clinical
endpoints (hospital admissions, cardiovascular events,
coronary interventions and deaths). There was moder-
ate global agreement of 79% between CTA and SPECT
(kappa 0.483). With SPECT as the reference standard,
CTA had a sensitivity of 73%, a specificity of 80%, a
negative predictive value of 90%, and a positive
predictive value of 55%. Eleven patients (18%) under-
went subsequent cardiac catheterization, which proved
to be positive in 91% of patients. Compared with
catheterization, CTA and SPECT had positive predic-
tive values of 90% and 83%, respectively.
The current study supports the value of CTA as an
alternative modality for the evaluation of CAD in an
ethnically diverse, gender balanced inner-city outpa-
tient population, whereby CTA had a high negative
predictive value of 90% in comparison with SPECT.
Reported limitations of the study were the rather
small study population, the small portion of diabetes
patients (10%), the low number of invasive angio-
grams (18%), the relatively short follow-up period of
9 months, and the low event rate. Furthermore, in
comparing CTA with SPECT one has to realize that
SPECT perfusion imaging and CTA provide different
and complementary information on CAD, namely
detection of ischemia versus detection of atheroscle-
rosis. This might explain the discordant findings in 13
patients i.e. 46 had a normal SPECT and 33 patients a
normal CTA. Either a non-critical stenosis (i.e.
normal CTA) may still give rise to a perfusion defect
(certainly in case of a cut-off value of 70% for a
critical stenosis), or a normal SPECT may occur
with anatomically significant—but hemodynamically
insignificant—atherosclerosis. In addition, seven
patients could not be evaluated by CTA. Lastly, as
the mean pretest-likelihood was rather low (30%), the
number of false positives tend to increase which may
affect specificity. Nevertheless, the study of Haramati
et al. [41] is a very valuable contribution to the early
identification of coronary atherosclerosis in an ethni-
cally heterogeneous group of inner-city outpatients.
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